Green Lifescience Co., Ltd. (KOSDAQ: 114450)
South Korea
· Delayed Price · Currency is KRW 1,683.00
-68.00 (-3.88%)
Dec 20, 2024, 1:52 PM KST
Green Lifescience Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -12,664 | -16,358 | -3,526 | -3,136 | -1,059 | 1,196 | Upgrade
|
| Depreciation & Amortization | 1,184 | 2,476 | 2,769 | 2,565 | 2,668 | 3,380 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -1.39 | 2.24 | - | -11.44 | Upgrade
|
| Asset Writedown & Restructuring Costs | 12,095 | 12,095 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -241 | -43.71 | -694.8 | -416.74 | -636.86 | -82.79 | Upgrade
|
| Provision & Write-off of Bad Debts | 49.5 | 49.5 | -34.85 | 17.15 | -37.59 | 23.41 | Upgrade
|
| Other Operating Activities | 506.27 | 693.59 | 1,364 | -369.63 | 1,241 | 175.19 | Upgrade
|
| Change in Accounts Receivable | 1,976 | 984.56 | 871.71 | -1,716 | 3,714 | -2,435 | Upgrade
|
| Change in Inventory | 785.02 | 460.55 | -782.87 | 1,270 | -2,571 | 1,001 | Upgrade
|
| Change in Accounts Payable | -632.14 | -84.25 | -3,276 | 1,277 | 305.68 | 1,223 | Upgrade
|
| Change in Unearned Revenue | - | - | 34 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 84.47 | 97.1 | -1,274 | 1,118 | -1,721 | -227.96 | Upgrade
|
| Operating Cash Flow | 3,143 | 370.02 | -4,552 | 611.38 | 1,902 | 4,242 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -67.86% | -55.15% | -21.12% | Upgrade
|
| Capital Expenditures | -969.63 | -495.69 | -1,478 | -3,444 | -2,667 | -3,600 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 1.5 | 2.1 | - | 11.5 | Upgrade
|
| Sale (Purchase) of Intangibles | -10.2 | -10.2 | - | - | - | - | Upgrade
|
| Investment in Securities | 5,751 | 7,791 | 6,489 | 2,948 | -5,223 | 6,507 | Upgrade
|
| Other Investing Activities | -7.23 | 230.75 | 44.54 | -108.34 | - | - | Upgrade
|
| Investing Cash Flow | 4,764 | 7,516 | 5,057 | -602 | -7,890 | 2,918 | Upgrade
|
| Short-Term Debt Issued | - | 15,753 | 9,552 | 10,128 | 8,661 | 5,490 | Upgrade
|
| Total Debt Issued | -0 | 15,753 | 9,552 | 10,128 | 8,661 | 5,490 | Upgrade
|
| Short-Term Debt Repaid | - | -17,441 | -10,418 | -8,911 | -7,544 | -5,490 | Upgrade
|
| Long-Term Debt Repaid | - | -221.77 | -205.29 | -256.23 | -217.28 | -182.26 | Upgrade
|
| Total Debt Repaid | -1,076 | -17,663 | -10,623 | -9,167 | -7,761 | -5,672 | Upgrade
|
| Net Debt Issued (Repaid) | -1,076 | -1,910 | -1,071 | 961.34 | 899.98 | -182.26 | Upgrade
|
| Repurchase of Common Stock | -3,824 | -2,366 | - | - | - | - | Upgrade
|
| Other Financing Activities | -144.84 | -30.84 | 0 | -0 | - | - | Upgrade
|
| Financing Cash Flow | -5,017 | -4,307 | -1,071 | 961.34 | 899.98 | -182.26 | Upgrade
|
| Foreign Exchange Rate Adjustments | -178.46 | -45.14 | -7.69 | 15.17 | -23.34 | 12.87 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | 2,711 | 3,533 | -573.99 | 985.91 | -5,112 | 6,990 | Upgrade
|
| Free Cash Flow | 2,173 | -125.67 | -6,030 | -2,832 | -765.1 | 641.22 | Upgrade
|
| Free Cash Flow Margin | 10.07% | -0.56% | -16.52% | -11.18% | -3.12% | 1.70% | Upgrade
|
| Free Cash Flow Per Share | 112.05 | -6.30 | -301.02 | -141.57 | -38.45 | 32.18 | Upgrade
|
| Cash Interest Paid | 181.19 | 226.53 | 163.84 | 18.33 | 27.14 | 35.02 | Upgrade
|
| Cash Income Tax Paid | - | -69.58 | 83.73 | -0.45 | -15.99 | -200.16 | Upgrade
|
| Levered Free Cash Flow | 1,651 | 812.18 | -4,933 | -1,743 | -900.07 | 47.36 | Upgrade
|
| Unlevered Free Cash Flow | 1,781 | 962.45 | -4,862 | -1,730 | -888.27 | 61.4 | Upgrade
|
| Change in Net Working Capital | -2,220 | -1,895 | 3,680 | -2,054 | -304.55 | 87.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.